| A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments KC Barry, J Hsu, ML Broz, FJ Cueto, M Binnewies, AJ Combes, ... Nature medicine 24 (8), 1178-1191, 2018 | 801 | 2018 |
| Unleashing type-2 dendritic cells to drive protective antitumor CD4+ T cell immunity M Binnewies, AM Mujal, JL Pollack, AJ Combes, EA Hardison, KC Barry, ... Cell 177 (3), 556-571. e16, 2019 | 501 | 2019 |
| The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies T Bald, MF Krummel, MJ Smyth, KC Barry Nature immunology 21 (8), 835-847, 2020 | 306 | 2020 |
| Secreted Bacterial Effectors That Inhibit Host Protein Synthesis Are Critical for Induction of the Innate Immune Response to Virulent Legionella pneumophila MF Fontana, S Banga, KC Barry, X Shen, Y Tan, ZQ Luo, RE Vance PLoS pathogens 7 (2), e1001289, 2011 | 237 | 2011 |
| IL-1α signaling initiates the inflammatory response to virulent Legionella pneumophila in vivo KC Barry, MF Fontana, JL Portman, AS Dugan, RE Vance The Journal of Immunology 190 (12), 6329-6339, 2013 | 145 | 2013 |
| Wash functions downstream of Rho and links linear and branched actin nucleation factors R Liu, MT Abreu-Blanco, KC Barry, EV Linardopoulou, GE Osborn, ... Oxford University Press for The Company of Biologists Limited 136 (16), 2849 …, 2009 | 122 | 2009 |
| Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment H Starobinets, J Ye, M Broz, K Barry, J Goldsmith, T Marsh, F Rostker, ... The Journal of clinical investigation 126 (12), 4417-4429, 2016 | 80 | 2016 |
| Discovering dominant tumor immune archetypes in a pan-cancer census AJ Combes, B Samad, J Tsui, NW Chew, P Yan, GC Reeder, D Kushnoor, ... Cell 185 (1), 184-203. e19, 2022 | 75 | 2022 |
| Degringolade, a SUMO‐targeted ubiquitin ligase, inhibits Hairy/Groucho‐mediated repression M Abed, KC Barry, D Kenyagin, B Koltun, TM Phippen, JJ Delrow, ... The EMBO journal 30 (7), 1289-1301, 2011 | 73 | 2011 |
| Positive and negative regulation of the master metabolic regulator mTORC1 by two families of Legionella pneumophila effectors JA De Leon, J Qiu, CJ Nicolai, JL Counihan, KC Barry, L Xu, ... Cell reports 21 (8), 2031-2038, 2017 | 59 | 2017 |
| The natural killer–dendritic cell immune axis in anti-cancer immunity and immunotherapy EE Peterson, KC Barry Frontiers in immunology 11, 621254, 2021 | 44 | 2021 |
| Global analysis of gene expression reveals mRNA superinduction is required for the inducible immune response to a bacterial pathogen KC Barry, NT Ingolia, RE Vance Elife 6, e22707, 2017 | 44 | 2017 |
| Pseudomonas aeruginosa quorum-sensing molecule homoserine lactone modulates inflammatory signaling through PERK and eI-F2α MA Grabiner, Z Fu, T Wu, KC Barry, C Schwarzer, TE Machen The Journal of Immunology 193 (3), 1459-1467, 2014 | 38 | 2014 |
| The Drosophila STUbL protein Degringolade limits HES functions during embryogenesis KC Barry, M Abed, D Kenyagin, TR Werwie, O Boico, A Orian, ... Development 138 (9), 1759-1769, 2011 | 34 | 2011 |
| Holistic characterization of tumor monocyte-to-macrophage differentiation integrates distinct immune phenotypes in kidney cancer AM Mujal, AJ Combes, AA Rao, M Binnewies, B Samad, J Tsui, ... Cancer immunology research 10 (4), 403-419, 2022 | 23 | 2022 |
| A framework for fibrolamellar carcinoma research and clinical trials TA Dinh, AF Utria, KC Barry, R Ma, GK Abou-Alfa, JD Gordan, EM Jaffee, ... Nature reviews Gastroenterology & hepatology 19 (5), 328-342, 2022 | 21 | 2022 |
| FLT3L release by natural killer cells enhances response to radioimmunotherapy in preclinical models of HNSCC TE Bickett, M Knitz, LB Darragh, S Bhatia, B Van Court, J Gadwa, ... Clinical Cancer Research 27 (22), 6235-6249, 2021 | 18 | 2021 |
| geneshot: gene-level metagenomics identifies genome islands associated with immunotherapy response SS Minot, KC Barry, C Kasman, JL Golob, AD Willis Genome Biology 22 (1), 135, 2021 | 8 | 2021 |
| Positive and negative regulation of the master metabolic regulator mTORC1 by two families of Legionella pneumophila effectors. Cell Rep 21: 2031–2038 JA De Leon, J Qiu, CJ Nicolai, JL Counihan, KC Barry, L Xu, ... | 6 | 2017 |
| A pan-cancer census of dominant tumor immune archetypes AJ Combes, B Samad, J Tsui, NW Chew, P Yan, GC Reeder, D Kushnoor, ... Biorxiv, 2021.04. 26.441344, 2021 | 3 | 2021 |
Matthew KrummelProfessor of Pathology, ImmunoX, UCSFVerified email at ucsf.edu
